Cognetivity Neurosciences Current Ratio vs. Shares Outstanding
| CGNSF Stock | USD 0 0 33.33% |
For Cognetivity Neurosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cognetivity Neurosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cognetivity Neurosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cognetivity Neurosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cognetivity Neurosciences over time as well as its relative position and ranking within its peers.
Cognetivity |
Cognetivity Neurosciences Shares Outstanding vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Cognetivity Neurosciences's current stock value. Our valuation model uses many indicators to compare Cognetivity Neurosciences value to that of its competitors to determine the firm's financial worth. Cognetivity Neurosciences is rated below average in current ratio category among its peers. It is rated fifth in shares outstanding category among its peers creating about 500,289,412 of Shares Outstanding per Current Ratio. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cognetivity Neurosciences' earnings, one of the primary drivers of an investment's value.Cognetivity Shares Outstanding vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Cognetivity Neurosciences |
| = | 0.17 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Cognetivity Neurosciences |
| = | 85.05 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Cognetivity Shares Outstanding Comparison
Cognetivity Neurosciences is currently under evaluation in shares outstanding category among its peers.
Cognetivity Neurosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Cognetivity Neurosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cognetivity Neurosciences will eventually generate negative long term returns. The profitability progress is the general direction of Cognetivity Neurosciences' change in net profit over the period of time. It can combine multiple indicators of Cognetivity Neurosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Cognetivity Neurosciences Ltd. operates as a healthcare company. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada. Cognetivity Neurosciences operates under Health Information Services classification in the United States and is traded on OTC Exchange.
Cognetivity Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Cognetivity Neurosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cognetivity Neurosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cognetivity Neurosciences' important profitability drivers and their relationship over time.
Use Cognetivity Neurosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cognetivity Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cognetivity Neurosciences will appreciate offsetting losses from the drop in the long position's value.Cognetivity Neurosciences Pair Trading
Cognetivity Neurosciences Pair Trading Analysis
The ability to find closely correlated positions to Cognetivity Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cognetivity Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cognetivity Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cognetivity Neurosciences to buy it.
The correlation of Cognetivity Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cognetivity Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cognetivity Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cognetivity Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Cognetivity Neurosciences position
In addition to having Cognetivity Neurosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Municipals ETFs Thematic Idea Now
Broad Municipals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Municipals ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Municipals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Cognetivity Pink Sheet
To fully project Cognetivity Neurosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Cognetivity Neurosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Cognetivity Neurosciences' income statement, its balance sheet, and the statement of cash flows.